Search





Search





Markets
/
Stocks
/
hrmy
/

Harmony Biosciences Holdings Inc

HRMY

Add to Watchlist

35.760USD

-0.250-0.69%

Close 07-28 16:00（ET）Quotes delayed by 15 min

2.07BMarket Cap

14.15P/E TTM

Harmony Biosciences Holdings Inc

35.760

-0.250-0.69%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

HRMY Cash Flow Statement

You can access the annual and quarterly cash flow statements of Harmony Biosciences Holdings Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-18.32%27.76M

66.95%126.15M

54.23%108.73M

86.14%79.33M

9.14%33.99M

-1.44%75.56M

11.73%70.50M

14.99%42.62M

-26.83%31.14M

187.37%76.67M

14.30%63.10M

9.88%37.06M

47.51%42.56M

-28.92%26.68M

81.45%55.20M

86.67%33.73M

130.26%28.85M

273.57%37.53M

244.24%30.42M

273.97%18.07M

146.93%12.53M

--10.05M

--8.84M

--4.83M

---26.70M

Net income from continuing operations

-28.69%32.49M

-54.55%22.49M

10.35%50.87M

243.16%39.78M

18.85%45.56M

85.95%49.48M

19.84%46.09M

-66.21%11.59M

30.01%38.33M

-45.15%26.61M

-56.27%38.46M

45.77%34.30M

37.24%29.48M

113.56%48.51M

1014.17%87.94M

66.69%23.53M

190.89%21.48M

11020.19%22.71M

-603.40%-9.62M

52385.19%14.12M

119.12%7.39M

---208.00K

--1.91M

---27.00K

---38.62M

Operating gains losses

0.00%5.97M

24.53%7.43M

0.00%5.97M

-1.40%5.97M

-2.55%5.97M

-2.56%5.97M

-2.26%5.97M

-0.20%6.05M

0.99%6.12M

0.94%6.13M

0.71%6.11M

0.15%6.06M

16.64%6.06M

27.48%6.07M

29.77%6.06M

28.04%6.05M

11.11%5.20M

8.60%4.76M

137.52%4.67M

135.98%4.73M

148.49%4.68M

--4.38M

--1.97M

--2.00M

--1.88M

Deferred tax

10.39%-3.86M

209.89%7.38M

19.65%-3.88M

54.58%-6.49M

-23.99%-4.31M

-697.68%-6.71M

30.07%-4.83M

-240.54%-14.28M

-1.02%-3.48M

126.34%1.12M

91.54%-6.91M

---4.19M

---3.44M

---4.26M

---81.68M

----

Other non-cash items

24094.74%32.18M

414.10%4.85M

2732.24%14.67M

-64.59%15.11M

43.01%133.00K

-59.05%943.00K

-95.17%518.00K

13113.31%42.68M

118.86%93.00K

160.23%2.30M

1549.38%10.72M

-63.67%323.00K

-146.29%-493.00K

46.77%885.00K

-97.59%650.00K

44.08%889.00K

73.45%1.06M

-82.74%603.00K

1172.20%27.00M

-23.83%617.00K

-97.47%614.00K

--3.49M

--2.12M

--810.00K

--24.23M

Change in working capital

-91.91%-49.63M

368.11%74.04M

157.54%30.14M

193.01%13.50M

-27.23%-25.86M

-50.02%15.82M

73.96%11.70M

-105.03%-14.51M

-643.21%-20.33M

198.87%31.64M

-81.02%6.73M

-76.01%-7.08M

206.16%3.74M

-708.69%-32.01M

759.71%35.45M

24.11%-4.02M

-2.17%-3.52M

1284.23%5.26M

133.60%4.12M

-427.97%-5.30M

76.31%-3.45M

---444.00K

--1.77M

--1.62M

---14.56M

-Change in receivables

50.14%-11.44M

352.38%3.86M

-563.44%-7.67M

477.78%12.99M

-311.11%-22.94M

77.73%-1.53M

147.94%1.66M

69.40%-3.44M

-357.69%-5.58M

-2215.69%-6.88M

34.16%-3.45M

3.87%-11.24M

165.81%2.17M

119.85%325.00K

-160.72%-5.24M

-54.21%-11.69M

-128.63%-3.29M

72.02%-1.64M

-85.00%-2.01M

-92.83%-7.58M

79.60%-1.44M

---5.85M

---1.09M

---3.93M

---7.05M

-Change in inventory

-90.66%76.00K

638.87%1.52M

38.52%-782.00K

32.71%284.00K

264.78%814.00K

-2.54%-283.00K

-445.92%-1.27M

128.01%214.00K

-338.65%-494.00K

30.48%-276.00K

-175.65%-233.00K

-296.40%-764.00K

225.45%207.00K

-206.43%-397.00K

110.96%308.00K

171.25%389.00K

71.65%-165.00K

124.67%373.00K

164.04%146.00K

-157.55%-546.00K

25.67%-582.00K

---1.51M

---228.00K

---212.00K

---783.00K

-Change in prepaid expenses

-49.87%-3.00M

1248.07%24.84M

1579.10%12.53M

-534.87%-3.59M

41.87%-2.00M

0.55%1.84M

78.75%-847.00K

-134.56%-565.00K

-680.91%-3.44M

159.73%1.83M

-416.32%-3.99M

211.07%1.64M

126.49%592.00K

-244.49%-3.07M

75.04%-772.00K

-351.53%-1.47M

-655.07%-2.23M

32.25%2.12M

40.31%-3.09M

-129.00%-326.00K

92.80%-296.00K

--1.61M

---5.18M

--1.12M

---4.11M

-Change in other current assets

----

-105.06%-64.00K

----

-100.00%0.00

--1.27M

---1.27M

--57.00K

--732.00K

-Change in other current liabilities

----

--2.00K

-300.00%-2.00K

---1.00K

100.00%0.00

-98.11%1.00K

100.00%0.00

-375.00%-152.00K

-227.56%-162.00K

282.76%53.00K

82.76%-5.00K

-136.36%-32.00K

--127.00K

---29.00K

--88.00K

Cash from non-recurring investing activities

Cash from operating activities

-18.32%27.76M

66.95%126.15M

54.23%108.73M

86.14%79.33M

9.14%33.99M

-1.44%75.56M

11.73%70.50M

14.99%42.62M

-26.83%31.14M

187.37%76.67M

14.30%63.10M

9.88%37.06M

47.51%42.56M

-28.92%26.68M

81.45%55.20M

86.67%33.73M

130.26%28.85M

273.57%37.53M

244.24%30.42M

273.97%18.07M

146.93%12.53M

--10.05M

--8.84M

--4.83M

---26.70M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

3673.29%19.36M

2266.67%71.00K

-99.37%4.00K

2460.00%128.00K

379.44%513.00K

--3.00K

208.29%632.00K

--5.00K

--107.00K

-100.00%0.00

400.00%205.00K

-100.00%0.00

--0.00

-7.53%86.00K

-79.60%41.00K

-59.96%40.05M

--0.00

--93.00K

9950.00%201.00K

--100.00M

--0.00

--2.00K

--0.00

Capital expenditures

-100.00%0.00

3673.29%19.36M

2266.67%71.00K

-99.37%4.00K

2460.00%128.00K

379.44%513.00K

--3.00K

208.29%632.00K

--5.00K

--107.00K

-100.00%0.00

400.00%205.00K

-100.00%0.00

--0.00

-7.53%86.00K

-79.60%41.00K

-59.96%40.05M

--0.00

--93.00K

9950.00%201.00K

--100.00M

--0.00

--2.00K

--0.00

Net cash flow from disposal of fixed assets

-100.00%0.00

-79.14%107.00K

2266.67%71.00K

-99.37%4.00K

2460.00%128.00K

379.44%513.00K

--3.00K

208.29%632.00K

--5.00K

--107.00K

-100.00%0.00

400.00%205.00K

-100.00%0.00

--0.00

-7.53%86.00K

-79.60%41.00K

1025.00%45.00K

--0.00

--93.00K

9950.00%201.00K

--4.00K

--0.00

--2.00K

--0.00

Net cash flow from intangible asset transactions

----

--19.25M

----

--0.00

-100.00%0.00

--0.00

-60.00%40.00M

--0.00

--100.00M

----

--0.00

Net cash flow from business transactions

----

100.00%0.00

--0.00

---33.07M

----

---36.97M

----

Net cash flow from investment products

-6190.20%-151.65M

130.38%1.72M

-730.75%-4.72M

-205.52%-4.58M

140.28%2.49M

-662.34%-5.67M

192.00%748.00K

157.43%4.34M

-245.31%-6.18M

102.15%1.01M

97.49%-813.00K

66.23%-7.57M

---1.79M

---46.90M

---32.36M

---22.41M

----

Net cash flow from other investing activities

---32.00M

100.00%0.00

--0.00

41.18%-15.00M

----

---1.00M

--0.00

---25.50M

----

---2.00M

----

Cash from non-current investing activities

Net cash flow from investing activities

-7875.02%-183.65M

-145.35%-17.63M

-742.82%-4.79M

64.29%-19.59M

138.18%2.36M

80.07%-7.19M

191.64%745.00K

-605.91%-54.86M

-245.59%-6.19M

23.09%-36.06M

97.49%-813.00K

65.38%-7.77M

95.53%-1.79M

---46.90M

-34787.10%-32.45M

-11067.66%-22.45M

59.96%-40.05M

100.00%0.00

---93.00K

-9950.00%-201.00K

---100.00M

---2.00M

--0.00

---2.00K

--0.00

Financing cash flow

Cash flow from continuous financing activities

-1950.57%-7.22M

-10.00%-3.02M

-154.98%-3.00M

22.05%-2.69M

90.31%-352.00K

94.88%-2.74M

97.87%-1.18M

-916.52%-3.45M

-206.60%-3.63M

-2113.66%-53.52M

-2787.76%-55.10M

-145.20%-339.00K

146.49%3.41M

-62.42%2.66M

754.95%2.05M

15.74%750.00K

11425.00%1.38M

711.76%7.07M

-100.23%-313.00K

1067.16%648.00K

-99.98%12.00K

---1.16M

--136.62M

---67.00K

--73.76M

Net cash flow from debt Issuance/repayment

-33.33%-5.00M

0.00%-3.75M

-207.14%-3.75M

-650.00%-3.75M

800.00%3.50M

0.00%-500.00K

---500.00K

--0.00

-100.00%0.00

--0.00

--97.46M

Net cash flow from common stock issuance/repurchase

----

-12154.90%-50.00M

-12354.90%-50.00M

----

---408.00K

-98.64%408.00K

----

--0.00

-79.68%30.00M

100.00%0.00

----

--0.00

--147.63M

---167.00K

----

Proceeds from stock option exercised by employees

-92.63%347.00K

-18.20%2.65M

-70.72%754.00K

265.97%2.10M

3956.90%4.71M

1325.99%3.24M

955.33%2.58M

-15.11%573.00K

-97.03%116.00K

-93.63%227.00K

-88.61%244.00K

-46.00%675.00K

107.59%3.91M

-52.94%3.57M

88.89%2.14M

92.90%1.25M

15591.67%1.88M

47256.25%7.58M

3443.75%1.13M

548.00%648.00K

-92.05%12.00K

--16.00K

--32.00K

--100.00K

--151.00K

Net cash flow from other financing activities

-96.10%-2.56M

70.24%-663.00K

--0.00

-284.01%-1.03M

---1.31M

---2.23M

100.00%0.00

47.67%-269.00K

----

--0.00

---8.84M

---514.00K

----

100.00%0.00

----

99.57%-5.00K

-184.90%-31.45M

--0.00

100.00%0.00

---1.17M

---11.04M

--0.00

---23.85M

Net cash from non-recurrent financing activities

Net cash from financing activities

-1950.57%-7.22M

-10.00%-3.02M

-154.98%-3.00M

22.05%-2.69M

90.31%-352.00K

94.88%-2.74M

97.87%-1.18M

-916.52%-3.45M

-206.60%-3.63M

-2113.66%-53.52M

-2787.76%-55.10M

-145.20%-339.00K

146.49%3.41M

-62.42%2.66M

754.95%2.05M

15.74%750.00K

11425.00%1.38M

711.76%7.07M

-100.23%-313.00K

1067.16%648.00K

-99.98%12.00K

---1.16M

--136.62M

---67.00K

--73.76M

Net cash flow

Beginning cash balance

66.08%752.77M

66.98%647.27M

72.03%546.32M

46.82%489.27M

45.31%453.27M

19.33%387.64M

-0.03%317.57M

15.43%333.25M

27.56%311.93M

23.95%324.85M

33.88%317.67M

28.17%288.71M

4.03%244.53M

37.61%262.09M

47.90%237.28M

58.72%225.25M

2.48%235.06M

-14.40%190.45M

108.28%160.44M

96.38%141.92M

809.99%229.38M

--222.49M

--77.03M

--72.27M

--25.21M

Current period cash flow changes

-553.10%-163.10M

60.74%105.50M

44.07%100.95M

463.74%57.05M

68.83%36.00M

607.89%65.63M

874.83%70.07M

-154.17%-15.69M

-51.74%21.32M

26.40%-12.92M

-71.03%7.19M

140.59%28.95M

550.34%44.18M

-139.37%-17.56M

-17.35%24.81M

-35.01%12.03M

88.78%-9.81M

547.29%44.60M

-79.36%30.02M

288.77%18.52M

-285.85%-87.46M

--6.89M

--145.46M

--4.76M

--47.06M

Ending cash balance

20.52%589.67M

66.08%752.77M

66.98%647.27M

72.03%546.32M

46.82%489.27M

45.31%453.27M

19.33%387.64M

-0.03%317.57M

15.43%333.25M

27.56%311.93M

23.95%324.85M

33.88%317.67M

28.17%288.71M

4.03%244.53M

37.61%262.09M

47.90%237.28M

58.72%225.25M

2.48%235.06M

-14.40%190.45M

108.28%160.44M

96.38%141.92M

--229.38M

--222.49M

--77.03M

--72.27M

Free cash flow

-18.01%27.76M

42.30%106.79M

54.14%108.66M

88.93%79.32M

8.75%33.86M

-1.97%75.05M

11.72%70.50M

13.91%41.98M

-26.84%31.14M

186.97%76.56M

14.48%63.10M

9.40%36.86M

480.23%42.56M

-28.92%26.68M

81.72%55.12M

88.54%33.69M

87.20%-11.19M

273.57%37.53M

243.19%30.33M

269.96%17.87M

-227.59%-87.47M

--10.05M

--8.84M

--4.83M

---26.70M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Harmony Biosciences Holdings Inc Generate?



Harmony Biosciences Holdings Inc generated 348.20M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Harmony Biosciences Holdings Inc's Operating Cash Flow Change Year Over Year?



Harmony Biosciences Holdings Inc's operating cash flow increased by 58.40% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Harmony Biosciences Holdings Inc Spend on Capital Expenditures?



Harmony Biosciences Holdings Inc spent 19.56M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Harmony Biosciences Holdings Inc's Financing Cash Flow Changed?



Harmony Biosciences Holdings Inc used -9.05M in financing activities in the latest quarter.

What is free cash flow and why does it matter for HRMY?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Harmony Biosciences Holdings Inc’s free cash flow in the latest quarter?



Free cash flow was 328.64M reflecting a 50.29% change from the previous year.